PTPI earnings: a negative outcome, -19.5%

On March 31, 2025, Petros Pharmaceuticals, Inc. reached its earnings. The result was a negative outcome, and the stock moved -19.5% in the window around the event. It had already run -12.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.